This study was undertaken to investigate the growth performance and immune responses of broiler chicks fed diets supplemented with conjugated linoleic acid (CLA). Two hundred and forty day-old Arbor Acre male broiler chicks were randomly allotted into four dietary treatments with different inclusion levels of CLA (0, 2·5, 5·0 or 10·0 g pure CLA/kg) for 6 weeks. Growth performance, lysozyme activity, peripheral blood mononuclear cell (PBMC) proliferation, prostaglandin E 2 (PGE 2 ) synthesis and antibody production were investigated. There were no significant differences in growth performance among treatments (P . 0·05). Chicks fed 10·0 g CLA/kg diet produced 40 % and 49 % more lysozyme activity in serum and spleen than the control group at 21 d of age (P , 0·05). Dietary CLA enhanced the PBMC proliferation in response to concanavalin A at the age of 21 and 42 d (P , 0·05). Systemic and peripheral blood lymphocytic synthesis of PGE 2 in chicks fed 10·0 g CLA/kg diet was significantly decreased by 57 % and 42 % compared to chicks fed control diet (P , 0·05). Antibody production to sheep red blood cell and bovine serum albumin were elevated in either 2·5 or 10·0 g CLA/kg dietary treatments (P , 0·05). The results indicated dietary CLA could enhance the immune response in broiler chicks, but did not alter the growth performance.
Conjugated linoleic acid (CLA) is a collective name for the mixture of 18:2 fatty acids that have conjugated double bonds. CLA was found to act as a growth factor in rats (Chin et al. 1994) and pigs (Ostrowska et al. 1999; Szymczyk et al. 2000) , and a potential inhibitor of body fat accumulation (West et al. 1998; Ostrowska et al. 1999; Yamasaki et al. 2003) . Furthermore, it displayed anticarcinogenic, antiatherogenic, antidiabetic and immunomodulatory properties (Ip et al. 1991; Lee et al. 1994; Pariza et al. 2000 Pariza et al. , 2001 Belury, 2002) . It has already been reported that CLA increased lymphocyte proliferation Wong et al. 1997) and IL-2 levels in mice (Hayek et al. 1999) , and immunoglobin production in rats (Sugano et al. 1998) ; CLA also mediates protection against immune-induced wasting (Cook et al. 1993; Miller et al. 1994) , mucosal damage and growth failure in experimental colitis (Hontecillas et al. 2002) and antigen-induced type 1 hypersensitivity response (Whigham et al. 2001 (Whigham et al. , 2002 . A considerable amount of evidence concerning the immunomodulatory function of CLA has been found (O'Shea et al. 2004) , and an immuno-enhancing effect of CLA has been proposed.
Some of the properties of CLA are similar to those of n-3 PUFA. It was hypothesized that n-3 PUFA could enhance immune responses and disease resistance by reducing eicosanoid production, particularly prostaglandin E 2 (PGE 2 ). Because CLA is an analogue of linoleic acid, it affects the metabolism of n-6 PUFA, and may alter arachidonic acid-derived eicosanoid formation. However, it appears that CLA modulation of eicosanoid production is species specific (Belury, 2002) , and modulation in birds has not been investigated.
The effects of CLA on mammalian immune responses have been extensively studied but little is known about the effects of dietary CLA on chicken immunity. Though some studies in mammals demonstrate that dietary CLA enhances Ig production (Sugano et al. 1998; Yamasaki et al. 2000) , the effects of CLA on antibody production of chicks are still uncertain. Cook et al. (1993) showed that antibody production in chicks against sheep red blood cell (SRBC) was not affected by feeding CLA, while Takahashi et al. (2003) reported that dietary CLA enhanced anti-SRBC antibody production in broilers. Limited information is available on other measures of immune response in birds.
Modulation of the immune status of chickens may bring beneficial effects and provide a new avenue in improving poultry health and production. Therefore, it is important to understand the effects and mechanisms of dietary CLA on chicken immune responses. The purpose of the current study was to examine the effect of diets supplemented with CLA on the immune response of broiler chicks and to explore whether the immune modulation of CLA is through alteration of PGE 2 production. So, in this study we used CLA substituted for maize oil (rich in n-6 PUFA, i.e. linoleic acid), and examined dietary CLA (or different ratios of n-6 PUFA and CLA) on the growth performance, lysozyme activity in serum and spleen, peripheral blood mononuclear cell (PBMC) proliferation, PGE 2 in circulation, and PBMC and antibody production in broiler chickens.
Materials and methods

Dietary treatments and animal management
Two hundred and forty day-old male Arbor Acre broiler chickens were assigned to four diets containing 0 (control), 2·5, 5·0 or 10·0 g pure CLA/kg. Diets were prepared by adding 0 (control), 3·12, 6·24 or 12·48 g of a commercial CLA (Auhai Biotech Ltd, Qingdao, P.R. China) containing 80·1 % CLA (c9, t11 ¼ 39·2; t10, c12 ¼ 38·9; other CLA isomers ¼ 2·0) in the form of NEFA into every kilogram of diet. A corn -soyabean meal diet was used, and energy was adjusted using maize oil. Each treatment had six replications with ten birds each. Birds were fed for 6 weeks. Chicks had free access to food and water and were housed in wire cages and maintained on a 24 h constant-light programme. Temperatures in the chicken house were set to 338C for the first 3 d and were reduced by 38C each consecutive week until they reached 248C. Compositions of the control diets and nutrient levels for starters (1-21 d) and growers (22 -42 d) are presented in Table 1 . Body weights were recorded for each replicate on days 1, 21 and 42 of age, and feed intake was measured over these periods in order to calculate feed conversion ratio. All management of birds was in accordance with the guidelines of raising Arbor Acre broilers (Wang, 2000) . All procedures were approved by the Animal Care and Use Committee of the China Agricultural University.
Sample collection and analysis
Lysozyme assay
At the age of 21 and 42 d, one bird from each replication was selected to supply blood from the wing vein. Serum was collected to determine lysozyme activity according to the method of Kreukniet et al. (1994) with some modifications. A series of concentrations of crystalline lysozyme (L6876; Sigma, Shanghai) dissolved in phosphate buffer was used to make the standard curve. The standard dilution series of crystalline lysozyme and serum samples were measured for their lysozyme activity in the lysis of Micrococcus lysodeikticus (purchased from the Institute of Microbiology, Chinese Academy of Science, Beijing). For the determination of lysozyme activity in the spleen, one bird from each replication was killed by cervix dislocation and the spleen was removed. After the fat and membrane were trimmed, spleen tissue (0·5 g) was homogenized in 5 ml ice-cold saline water (0·85 %) and the homogenate was diluted to make a concentration of 1 mg/ml. The diluted homogenate was determined for lysozyme activity as that of serum.
Proliferation assay of peripheral blood mononuclear cell
In vitro PBMC proliferation response was determined using a previously described method (Mosmann, 1983; Lin, 1999) at the age of 21 and 42 d. The heparinized (20 U/ml) blood sample obtained by wing-vein puncture was added to the same volume of sterile Hanks balanced salt solution (HBSS) without Ca 2þ and Mg 2þ . The diluted blood mixture was layered over half its volume of sterile lymphocyte separation medium (density ¼ 1·077 -1·080, Academy of Military Medical Science, Beijing), and separated by density-gradient centrifugation at 400 g for 30 min at 48C to recover PBMC. PBMC were collected at the interface and washed with HBSS three times, then were suspended in 2 ml sterile RPMI 1640 media with NaHCO 3 (24 mM), L-glutamine (2 mM), sodium pyruvate (1 mM), HEPES (10 mM), penicillin (100 U/ml) and streptomycin (0·1 mg/ml). The live cells were detected by trpan blue dye exclusion using a microscope. Cell suspensions were diluted to a final concentration of 1 £ 10 7 cells/ml in RPMI 1640 medium. One hundred microlitres of cell suspension, and 100 ml RPMI 1640 in the absence or presence of 90 mg/ml concanavalin A (ConA; C2613, Sigma, Shanghai) or 50 mg/ml lipopolysaccharide (L3129, Sigma, Shanghai) were added into a 96-well plate (Costar 3599). The cultures were set up in triplicate. After 56 h incubation in a 5 % CO 2 incubator at 418C, 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyl tetrazolium salts (MTT, M2128, Sigma) were added to the cell culture to make a final concentration 5 mg/ml. The cells were incubated for a further 4 h, then 100 ml acidified isopropyl alcohol was added to the culture and vibrated for at least 10 min to dissolve the coloured material fully. The absorbance of each sample was read via an automated ELISA reader (Bio-Rad, Model 550) at 570 nm.
Prostaglandin E 2 assay
Serum and culture medium of PBMC from birds at the age of 21 and 42 d were determined for PGE 2 synthesis. PBMC was prepared as described above (see section on proliferation of PBMC). Lymphocytes (1 £ 10 7 per well) were cultured in 24-well culture plates (Costar 3524). Cells were coincubated with 45 mg/ml ConA for 48 h at 408C in a 5 % CO 2 atmosphere. At the end of incubation, cells and medium were collected and centrifuged at 2000 g for 10 min at 48C. The supernatant fluid was stored at about 308C until assayed. PGE 2 of the culture medium of PBMC and serum was determined by RIA. An 125 I-PGE 2 kit with manual was purchased from the Institute of Atomic Energy Application, Chinese Academy of Agricultural Sciences, Beijing.
Antibody production
Six chicks at the age of 14 and 28 d fed on each diet were injected intraperitoneally with 1 ml of a 7 % SRBC. Serum antibody titres against SRBC were measured on the 6th, 10th and 14th day after the first injection and on the 5th, 9th and 13th day after the second injection by active haemagglutination test (Isakov et al. 1982) . Titres were expressed as the log 2 values of the highest dilution giving a positive reaction.
For bovine serum albumin (BSA), chickens were immunized with 2 ml of 0·5 % BSA in the thigh muscle on the 14th day and the 28th day of age. Serum total antibody titres to BSA were determined by ELISA from six birds for each treatment on the 6th, 10th and 14th day after primary sensitization, and on the 5th, 9th and 13th day after secondary immunization. Briefly, 96-well plates were coated with 4 mg/ml BSA. After subsequent washing with PBS and 0·05 % Tween, the plates were incubated with 1:80 serum (preliminary experiments had shown that in the assay a serum dilution of 1/80 resulted in absorbance in the linear part of the dilution -absorbance curve). Binding of BSAspecific IgG was determined using 1:20 000 peroxidase-labelled polyclonal antibody against chicken IgG (Sigma). After washing, tetramethylbenzidine and 0·05 % hydrogen peroxide were added and incubated for 10 min at room temperature. The reaction was stopped with 1·25 M-sulphuric acid. The colour was measured at 405 nm using an ELISA plate reader (Bio-Rad, Model 550) against the negative control (PBS replaced the diluted serum).
Statistical analysis
Data were reported as means and standard deviations and analysed by one-way ANOVA of SPSS 10.0. The significance of differences among different groups was evaluated by a least significant difference post hoc multiple comparisons test.
The correlation between PGE 2 and the proliferation of PBMC was analysed by the Pearson procedure of SPSS 10·0. Table 2 shows the effects of dietary CLA on growth performance in broiler chicks.The differences in feed intake, body weight gain and feed conversion rate among treatments were not statistically significant across different growth periods (P. 0·05). Table 3 shows the results of dietary CLA on lysozyme activity in chicks. At the age of 21 d, chicks fed the highest level of CLA diet had significantly higher lysozyme activity compared with chicks fed control diet (P,0·05); the spleen lysozyme activities of chicks in the highest level of CLA treatment group were significantly higher than those of the control group and other CLA groups (P,0·05). However, at the age of 42 d, no differences in lysozyme activities were observed among treatments in either serum or spleen. Table 4 shows the results of the effects of dietary CLA on proliferation of peripheral blood lymphocyte in young chicks. At the age of 21 d, when mitogen (lipopolysaccharide or ConA) was added into the culture media, PBMC proliferations in chicks fed 10·0 g CLA/kg diet were significant enhanced than in chicks fed control diet or other CLA diets (P,0·05). At the age of 42 d, PBMC proliferations in response to ConA were enhanced in chicks fed 5·0 and 10·0 g CLA/kg diet compared to chicks fed control diet (P, 0·05). Proliferation of the unstimulated cells did not vary among treatments at both 21 and 42 d of age. Table 5 shows the results of PGE 2 concentration in serum and culture medium of PBMC. Systemic and peripheral blood lymphocytic PGE 2 synthesis in birds fed 10·0 g CLA/kg diet was 577·9  24·6  591·3  27·5  571·5  29·4  539·1  26·5  3-6 wk  1285·3  93·8  1319·5  98·2  13 223·4  107·6  1345·8  82·7  0-6 wk  1858·5  117·3  1910·8  96·8  1894·9  113·6  1890·2  75·3  Feed intake (g)  0-3 wk  785·5  76·2  787·1  42·1  776·9  65·8  759·4  36·2  3-6 wk  2680·3  168·5  2645·0  171·2  2713·7  239·8  2583·0  173·9  0-6 wk  3441·8  226·4  3432·1  181·3  3468·6  248·6  3377·5  163·5  Feed conversion ratio  0-3 wk  1·328  0·101  1·334  0·097  1·358  0·055  1·408  0·088  3-6 wk  2·054  0·025  2·011  0·048  2·072  0·086  1·928  0·079  0-6 wk  1·868  0·043  1·800  0·066  1·849  0·104  1·795  0·033 * For details of procedures, see p. 747.
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significantly decreased compared with birds fed control diet at both 21 and 42 d of age (P, 0·05). The influence of dietary CLA on PGE 2 in circulation and PBMC were similar except that serum PGE 2 in chicks fed 2·5 g CLA/kg diet was significantly lower than in those in the control group at the age of 21 d (P, 0·05). Tables 6 and 7 show the effects of dietary CLA on the antibody production of primary and secondary challenge in chicks. Anti-SRBC titres in birds fed 2·5 g CLA/kg diet were higher than birds given control diet 6 d after primary immunization (P, 0·05). Enhancement of anti-SRBC titres was observed in birds of the 10·0 g CLA/kg diet treatment group compared to those of the control group on 5d and 9 d after secondary immunization (P, 0·05). Higher anti-BSA titres were found at 10 d after primary immunization in birds given CLA diets than birds fed control diet (P, 0·05). Anti-BSA titres in chickens fed 2·5 g CLA/kg diet on days 10 and 4 after first challenge and day 5 after secondary challenge were significantly higher than those in the control group (P, 0·05).
Antibody production
Discussion
Some researchers have shown that feeding CLA at levels of 5 -10 g/kg diet improved feed efficiency, growth and/or meat production in rats (Chin et al. 1994) , mice (Dugan et al. 1997; West et al. 1998 ) and pigs (Ostrowska et al. 1999) . Our results demonstrated that dietary supplementation of CLA has no effect on growth performance in young chicks. This finding was similar to those of Simon et al. (2000) , and An et al. (2003) , i.e. dietary CLA had no significant effects on body gain, feed intake and feed efficiency in broiler chicks. Other researchers found that feeding CLA at levels of above 10 g/kg diet decreased the growth rate of mice (Belury & Kempa-steczko, 1997) , rats (Szymczyk et al. 2000) , broilers (Szymczyk et al. 2001; Badinga et al. 2003) and striped bass (Twibell et al. 2000) . The discrepancy of effects of CLA on animal growth performance could be ascribed to the differences in animal species, dietary CLA concentration, type of isomers of CLA, feeding periods and nutritional status of the animals. West et al. (1998) pointed out that decreased growth performance of mice accompanied by high dose (above 10 g/kg) of dietary CLA was due to the acceleration of fatty acid oxidation and enhancement of metabolic rate.
Lysozyme present in external secretions, polymorphonuclear leukocytes and macrophages is highly active against Gram-positive bacteria. After the internalization of antigens, destruction is likely accomplished by the lysosomal reservoir of hydrolytic enzymes and by the respiratory burst (i.e. O 2 2 and H 2 O 2 ; Melnick et al. 1985) . Hydrolytic enzymes, i.e. lysozyme and acid phosphatase found in the serum, can destroy the glucosidic bond in the cell wall of Escherichia coli and Staphylococcus as a result of the phagocytic activity (Wang et al. 1995) . The phagocyte is an important kind of accessory cell in immune response and antigen presentation. Higher levels of lysozyme activity suggested that CLA could stimulate the activation or antigen presentation of the phagocyte, thus enhancing the antibacterial defence of the body. The mechanism might be the decreased production of metabolites of n-6 fatty acids, such as PGE 2 , and changed membrane compositions of immune cells. Our results showed that CLA enhanced ConA-induced lymphocyte proliferation in broiler chicks. This is in agreement with the reports of Michal et al. (1992) and Cook et al. (1993) who noted that CLA-supplemented chicks challenged with lipopolysaccharide had higher T cell blastogenic response to phytohaemagglutinin.
Reported effects of CLA on immune cell functions varied from stimulation, inhibition to no influence Hayek et al. 1999; Bassaganya-Riera et al. 2001; Kelly et al. 2002) . These discrepancies may be due to culture conditions (serum type and concentration, mitogen and culture period), cell type (peritoneal v. splenocyte v. blood cells), composition of the diets, animal species and age of the animal. The differences in isomer composition of the CLA mixture may not be important, because it was reported that c9, t11-CLA and t10, c12-CLA had similar effects on immune function in mice (Kelly et al. 2002) .
Our results indicated that CLA would enhance ConA-induced T cell stimulation. The immune enhancement may be beneficial to fast-growing broiler chicks that are highly responsive to stress caused by vaccination, population density, ammonia concentration and environmental temperature. These beneficial effects are yet to be determined. PGE 2 , one of the most important eicosanoids, is an endogenous inhibitor of immune response. PGE 2 inhibits proliferation of T cells and production of IL-2 and g-interferon from T cells (Hasler et al. 1983; Betz & Fox, 1991) . By using the Pearson procedure, negative correlations were found between PGE 2 synthesis of PBMC and proliferation of T cells at the age of 21 d (r 2 2 0·975, P¼ 0·013) and 42 d (r 2 2 0·706, P¼ 0·160). The reduction of PGE 2 was consistent with the observed enhanced proliferation of T cells in our study.
Dietary CLA has also been shown to decrease prostanoid levels in serum (Sugano et al. 1997 (Sugano et al. , 1998 , bone , spleen (Sugano et al. 1997 ) and cultured keratinocytes (Liu & Belury, 1997) . A number of reports have provided either direct or indirect evidence suggesting that CLA may interfere with prostaglandin production through a decrease in the supply of arachidonic acid precursor (Cook et al. 1993; Belury & Kempasteczko, 1997; Turek et al. 1998; Banni et al. 1999) . Arachidonic acid is the precursor for PGE 2 ; thus, increased CLA intake may decrease PGE 2 production. But, CLA replacement of phospholipid archidonic acid might not be adequate to cause a significant change in PGE 2 production. Other studies reported that CLA had no significant effect on PGE 2 production (Turek et al. 1998; Hayek et al. 1999) . Furthermore, dietary CLA reduced accumulation of the lipoxgenase products leukotriene-B4 and leukotriene-C4 in spleen and lung (Sugano et al. 1998) 
but not [
14 C]hydroxyeicosatetraenoic acid in cultured human platelets (Truitt et al. 1999) . Further studies are needed to determine whether the effect of CLA on PGE 2 production is species-, organ-or tissue-specific.
The reduction of arachidonate-derived eicosanoids by dietary CLA has been explained by at least three hypothesized mechanisms (Belury, 2002) : first, CLA displaces arachidonate in phospholipids; secondly, CLA reduces the expression of cyclooxygenase (the ratelimiting enzyme which catalyses the conversion of prostanoids from arachidonic acid); and thirdly, CLA or its metabolites act as substrates or antagonists for cyclooxygenase. Our study confirmed that CLA could decrease PGE 2 synthesis in chickens. The exact mechanism remains to be clarified in the future. Another possible explanation by which CLA decreases prostanoid may be downregulation of enzyme activity by phospholipase A 2 the enzyme responsible for cleaving precursor fatty acids from the phospholipid before cyclooxygenation or lipoxygenation.
The kinetics of antibody production in our study was not observed. It is possible that the modern chicks are more resistant to environment stress. However, the effects of dietary CLA on thymus-dependent antigen SRBC and BSA were elevated in the sample periods. The effects of CLA on humoral immunity were not in agreement among the earlier experiments. Antibody response in chicks to SRBC or rats to BSA was not affected by feeding CLA (Cook et al. 1993) . Takahashi et al. (2003) found that the first antibody titres against SRBC were higher in CLAfed chicks, but the second titres were not. Our study examined the kinetics of antibody response after primary and secondary immunization with three CLA dose supplementations and enhancement of anti-SRBC titres after primary and secondary immunization were observed. The reasons for the differences among experimental results are probably due to the route of antigen administration, dietary CLA concentration or fatty acid composition in the diet used (Takahashi et al. 2003) .
The higher antibody titres against BSA appeared on day 10 and day 9 after primary and secondary challenge, respectively. No dose-dependent response of dietary CLA on antibody production was found. In our study, it seemed that 2·5 g CLA/kg diet was optimal to enhance anti-BSA titres. So far, the effects of dietary CLA on antibody titres to BSA have been less clearly observed in birds.
The effects of dietary CLA on antibody production in the present study are comparable with the effects of n-3 fatty acids (Xia et al. 2003) . The mode of action of n-3 fatty acids has been estimated to be due to changes in PGE 2 or eicosanoid production (Xia et al. 2003; Guo et al. 2004) . However, comparing the effects on antibody production and PGE 2 synthesis, it seems that the enhancement of antibody production of dietary CLA may not be due to changes in eicosanoid production since the reduction of PGE 2 did not parallel with the elevation of antibody production. It remains elusive how CLA affects antibody production. Anyway, the present results in our study suggested that dietary CLA has the potential to elevate antibody production in chicks.
In conclusion, dietary CLA (, 10 g/kg diet) enhanced lysozyme activity, stimulated T lymphocyte proliferation, decreased PGE 2 synthesis and potentially elevated antibody production in male broiler chickens. The underlying mechanism is not clear. However, the young broiler chick offers a useful animal model to study the effect of CLA. Furthermore, the results of this series of studies will help not only the health of the animal but also the production of the broiler industry. 
